Tradename | Company | Number | Date | Products |
---|---|---|---|---|
IOBENGUANE SULFATE I 131 | Sun Pharmaceutical Industries | N-020084 DISCN | 1994-03-25 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADREVIEW | GE Healthcare | N-022290 RX | 2008-09-19 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
AZEDRA | Progenics Pharmaceuticals | N-209607 DISCN | 2018-07-30 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
adreview | New Drug Application | 2024-01-10 |
Expiration | Code | ||
---|---|---|---|
IOBENGUANE I-131, AZEDRA, PROGENICS PHARMS INC | |||
2025-07-30 | ODE-204 |
Drug common name | Iobenguane i 131 |
INN | iobenguane (131i) |
Description | 2-[(3-iodophenyl)methyl]guanidine is an organoiodine compound. |
Classification | Small molecule |
Drug class | iodine-containing contrast media |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N=C(N)NCc1cccc([131I])c1 |
PDB | — |
CAS-ID | 77679-27-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1615779 |
ChEBI ID | — |
PubChem CID | 60860 |
DrugBank | DB06704 |
UNII ID | Q461L7AK4R (ChemIDplus, GSRS) |